title: Brentuximab-induced hand-foot syndrome in a Hodgkin lymphoma patient.
authors.affiliation: Adult Hematology and BMT, Department of Oncology, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia. jaliljeddah@yahoo.com.
authors.forename: Jalil Ur
authors.initials: JU
authors.lastname: Rehman
authors.affiliation: Adult Hematology and BMT, Department of Oncology, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia. Mkelta@kfshrc.edu.sa.
authors.forename: Mouhammed
authors.initials: M
authors.lastname: Kelta
authors.affiliation: Adult Hematology and BMT, Department of Oncology, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia. Balbeirouti@kfshrc.edu.sa.
authors.forename: Basim
authors.initials: B
authors.lastname: AlBeirouti
authors.affiliation: Adult Hematology and BMT, Department of Oncology, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia. gradwi@kfshrc.edu.sa.
authors.forename: Radwi Ghazala
authors.initials: RG
authors.lastname: Rashidhaider
authors.affiliation: Pediatric Hematology/Oncology, Department of Oncology, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia. Mbayoumi@kfshrc.edu.sa.
authors.forename: Bayoumy
authors.initials: B
authors.lastname: Mohamed
mesh_terms: D000079963:Brentuximab Vedotin; D060831:Hand-Foot Syndrome / Q000175:diagnosis*; D006689:Hodgkin Disease / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D018796:Immunoconjugates / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged
chemical_list: D018796:Immunoconjugates; D000079963:Brentuximab Vedotin